Smith & Nephew (SNNUF) EBIT Margin Growth (3y) (2012 - 2024)
Smith & Nephew (SNNUF) EBIT Margin Growth (3y) (2012 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -3,846.00 |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 241.00 |
| Dec 31, 2022 | -755.00 |
| Dec 31, 2021 | -605.00 |
| Dec 31, 2020 | -1,797.00 |
| Dec 31, 2019 | 153.00 |
| Dec 31, 2018 | -408.00 |
| Dec 31, 2017 | 137.00 |
| Dec 31, 2016 | -392.00 |
| Dec 31, 2015 | -45.00 |
| Dec 31, 2014 | -300.00 |
| Sep 30, 2014 | -750.00 |
| Mar 31, 2014 | -41.00 |
| Dec 31, 2013 | -577.00 |
| Sep 28, 2013 | -436.00 |
| Jun 29, 2013 | -537.00 |
| Mar 31, 2013 | -2.50 Bn |
| Dec 31, 2012 | -1.77 Bn |
| Sep 29, 2012 | 1,964.00 |
| Jun 30, 2012 | 0.00 |
| Mar 31, 2012 | -1.77 Bn |